tm logo
Trademark Search
FIDVAXI

View On IC.GC.CA

FIDVAXI
APPROVED

on 26 Nov 2024

Last Applicant/ Owned by

Genexine, Inc.

(Magokdong, Bio Innovation Park) 172,Magokjungang-ro,Gangseo-guSeoul

KR

Serial Number

2216960 filed on 01st Sep 2022

Correspondent Address

240 Richmond Street WestToronto

ONTARIO

CA

M5V1V6

FIDVAXI

Trademark usage description

pharmaceutical preparations for the treatment of cancer, namely, immunomodulators; viral vaccines used to treat cancer and cancer tumor treatment; pha Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of cancer, namely, immunomodulators; Viral vaccines used to treat cancer and cancer tumor treatment; Pharmaceutical vaccines used to treat cancer and tumor treatment; Cervical cancer vaccines; Pharmaceutical preparation and substances namely vaccines for use in cervical cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; human vaccine preparations; Pharmaceutical preparations namely vaccines used for the treatment of cancer tumors in the field of gynecology; Pharmaceutical preparations namely vaccines used to suppress cancerous tumors; anti-cancer preparations.

Classification kind code

11

Mark Details

Serial Number

2216960

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 11th Mar 2024		Agent Changed
Submitted for opposition 22
on 01st Feb 2024		Search Recorded
Submitted for opposition 20
on 01st Feb 2024		Examiner's First Report
Submitted for opposition 223
on 01st Feb 2024		Total Provisional Refusal
Submitted for opposition 256
on 21st Aug 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 20th Oct 2022		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 19th Oct 2022		Formalized
Submitted for opposition 1
on 19th Oct 2022		Created
Submitted for opposition 228
on 01st Sep 2022		International Registration
Submitted for opposition 30
on 01st Sep 2022		Filed